All lobbying filings

JAZZ PHARMACEUTICALS, INC.

Lobbying for JAZZ PHARMACEUTICALS, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $410,000.00 expenses · posted Oct 17, 2025

Official filing document

Bills named in this filing 1

HR 946
ORPHAN Cures Act

Lobbying activity 1

Pharmacy

FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Issues related to the regulation of intoxicating hemp Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.